Zydus Wellness Limited Stock

Equities

ZYDUSWELL

INE768C01010

Food Processing

Market Closed - Bombay S.E. 06:00:54 2024-07-04 am EDT 5-day change 1st Jan Change
2,098 INR +1.63% Intraday chart for Zydus Wellness Limited +16.03% +24.72%
Sales 2024 23.28B 279M Sales 2025 * 25.92B 310M Capitalization 133B 1.6B
Net income 2024 2.67B 31.97M Net income 2025 * 3.94B 47.22M EV / Sales 2024 4.02 x
Net cash position 2024 76M 910K Net cash position 2025 * 2.06B 24.73M EV / Sales 2025 * 5.07 x
P/E ratio 2024
35.1 x
P/E ratio 2025 *
33.9 x
Employees 975
Yield 2024
0.34%
Yield 2025 *
0.26%
Free-Float 20.12%
More Fundamentals * Assessed data
Dynamic Chart
Transcript : Zydus Wellness Limited, Q4 2024 Earnings Call, May 14, 2024
Zydus Wellness Sees Rise in Fiscal Q4 Consolidated Net Profit MT
Zydus Wellness Limited Recommends Final Dividend, Payable on or After August 7, 2024 CI
Zydus Wellness Limited Reports Earnings Results for the Full Year Ended March 31, 2024 CI
Zydus Wellness Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024 CI
Zydus Wellness Limited and Heinz India Private Limited Receives Three Order from Central Goods and Services Tax Act, 2017 CI
Zydus Wellness Limited Receives an Order from the Assistant Commissioner, Saroor Nagar Division, Hyderabad CI
Zydus Wellness Limited Receives an Order of Assessment from the Assistant Commissioner (ST)(FAC), Vanasthalipuram-I Circle, Saroor Nagar Division, Hyderabad CI
India's Zydus Lifesciences beats Q3 profit estimates; approves shares buyback RE
Transcript : Zydus Wellness Limited, Q3 2024 Earnings Call, Feb 08, 2024
Zydus Wellness Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI
India's Zydus Q2 profit jumps on strong domestic, US demand RE
Transcript : Zydus Wellness Limited, Q2 2024 Earnings Call, Nov 06, 2023
India's Zydus Wellness profit drops on one-off deferred tax expense RE
Zydus Wellness Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023 CI
More news
1 day+1.63%
1 week+16.03%
Current month+17.48%
1 month+21.80%
3 months+35.30%
6 months+24.19%
Current year+24.72%
More quotes
1 week
1 775.00
Extreme 1775
2 120.95
1 month
1 707.05
Extreme 1707.05
2 120.95
Current year
1 441.75
Extreme 1441.75
2 120.95
1 year
1 425.00
Extreme 1425
2 120.95
3 years
1 363.85
Extreme 1363.85
2 472.85
5 years
1 070.00
Extreme 1070
2 472.85
10 years
568.00
Extreme 568
2 472.85
More quotes
Managers TitleAgeSince
Chief Executive Officer 52 15-05-13
Director of Finance/CFO - 18-02-06
Compliance Officer - 22-07-28
Members of the board TitleAgeSince
Chairman 44 09-04-26
Chief Executive Officer 52 15-05-13
Director/Board Member 50 19-03-10
More insiders
Date Price Change Volume
24-07-04 2,098 +1.63% 6 246
24-07-03 2,064 +7.53% 27,761
24-07-02 1,920 +2.82% 7,950
24-07-01 1,867 +4.56% 3,310
24-06-28 1,786 -0.54% 2,476

Delayed Quote Bombay S.E., July 04, 2024 at 06:00 am EDT

More quotes
Zydus Wellness Limited is an India-based consumer wellness company. The Company operates as an integrated consumer company with business encompassing the entire value chain in the development, production, marketing and distribution of health and wellness products. The product portfolio of the Company includes brands like Sugar Free, Everyuth, Nutralite, Complan, Glucon-D and Nycil. Glucon-D Regular variant is a source of vitamin D and Flavor variants are a rich source of vitamin C. Complan is a health food drink, scientifically designed for growing school children and contains nutrients along with milk protein. Sugar Free is a low-calorie sweetener, which is a replacement of sugar for the calorie-conscious, weight watchers and diabetics. Everyuth offers a range of skincare products under the brand name of Everyuth Naturals. Nycil prickly heat and cooling powder brand and has also expanded its portfolio into the hand sanitizer category.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
2,098 INR
Average target price
1,919 INR
Spread / Average Target
-8.54%
Consensus
  1. Stock Market
  2. Equities
  3. ZYDUSWELL Stock